Institutional Ownership Lineage Cell Therapeutics, Inc. (LCTX)
This table provides information about the institutional ownership of Lineage Cell Therapeutics, Inc. (LCTX). We have compiled data on the 121 institutions that hold shares in the stock, with a total of 94.2 Million shares, which have been reported (via 13F filing form) to have a value of $84.8 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Broadwood Capital Inc
New York, NY |
Nov 13, 2024 Q3 2024 |
41,666,255
shares
|
$26.7 Million
2.94% of portfolio
|
Q1 2024
Added 19.27%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
9,559,466
shares
|
$6.12 Million
0.0% of portfolio
|
Q2 2024
Added 12.54%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
8,600,995
shares
|
$5.5 Million
0.0% of portfolio
|
Q3 2024
Added 1.5%
|
|
|
Defender Capital, Llc.
|
Oct 21, 2024 Q3 2024 |
5,002,198
shares
|
$3.2 Million
1.58% of portfolio
|
Q3 2024
Added 0.59%
|
|
|
Logos Global Management LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
5,000,000
shares
|
$3.2 Million
0.6% of portfolio
|
Q3 2024
Added 6.38%
|
|
|
Raffles Associates LP
New York, NY |
Nov 14, 2024 Q3 2024 |
4,507,781
shares
|
$2.88 Million
4.64% of portfolio
|
Q3 2024
Added 3.44%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
3,679,280
shares
|
$2.35 Million
0.0% of portfolio
|
Q3 2024
Added 2.32%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,608,352
shares
|
$1.67 Million
0.0% of portfolio
|
Q3 2024
Added 1.77%
|
|
|
Mai Capital Management
|
Nov 07, 2024 Q3 2024 |
1,674,679
shares
|
$1.07 Million
0.02% of portfolio
|
Q3 2024
Added 2.19%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
1,372,422
shares
|
$878,350
0.0% of portfolio
|
Q3 2024
Added 0.84%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Nov 14, 2024 Q3 2024 |
1,350,708
shares
|
$864,453
0.32% of portfolio
|
Q2 2024
Reduced 1.14%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
1,274,573
shares
|
$815,726
0.0% of portfolio
|
Q3 2024
Added 6.99%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
848,291
shares
|
$542,906
0.0% of portfolio
|
Q3 2024
Added 61.08%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2024 Q3 2024 |
756,766
shares
|
$484,330
0.02% of portfolio
|
Q3 2024
Added 11.0%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
677,162
shares
|
$433,383
0.0% of portfolio
|
Q3 2024
Added 13.94%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
515,445
shares
|
$329,884
0.0% of portfolio
|
Q2 2023
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
416,223
shares
|
$266,382
0.0% of portfolio
|
Q3 2024
Reduced 0.05%
|
|
|
Prescott General Partners LLC
Boca Raton, FL |
Nov 14, 2024 Q3 2024 |
386,000
shares
|
$247,040
0.02% of portfolio
|
Q3 2024
Reduced 37.74%
|
|
|
ETF Managers Group, LLC
Summit, NJ |
Apr 17, 2023 Q1 2023 |
318,596
shares
|
$203,901
0.02% of portfolio
|
Q1 2023
Reduced 10.0%
|
|
|
Comerica Bank
|
Nov 14, 2024 Q3 2024 |
250,000
shares
|
$160,000
0.0% of portfolio
|
Q2 2024
Reduced 0.12%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
244,224
shares
|
$156,303
0.0% of portfolio
|
Q3 2024
Added 48.39%
|
|
|
Long Focus Capital Management, LLC
San Juan, PR |
Nov 13, 2024 Q3 2024 |
215,000
shares
|
$137,600
0.01% of portfolio
|
Q1 2023
Added 22.86%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
211,300
shares
|
$135,232
0.0% of portfolio
|
Q3 2024
Added 311.28%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
197,100
shares
|
$126,144
0.0% of portfolio
|
Q3 2024
Reduced 66.23%
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 08, 2024 Q3 2024 |
191,436
shares
|
$122,519
0.0% of portfolio
|
Q3 2024
Reduced 7.86%
|